PATH, Coalition for Access to NCD Medicines and Products
The case for financing action on noncommunicable diseases – even, and especially, in times of crisis
Briefs & Fact Sheets
28 May 2025
The Role of Health Technology Assessment in Medicine Pricing and Reimbursement
Health Action International (HAI)
27 Nov 2018
This policy brief summarises the key points from the review on the role of health technology assessment (HTA) in medicine pricing and reimbursement with a focus on its use in low- and middle-income countries (LMICs).
